Figure 7
Doxorubicin suppresses the expression of caspase 3 and PARP in fascin-positive breast cancer cells. (A) Graph showing the percentage of active form of caspase 3 expressing cells in ShCon or ShFascin group following the treatment with doxorubicin for 24 h. (B) Graph showing percentage of cleaved PARP-positive cells in ShCon or ShFascin group following the treatment with doxorubicin for 24 h. Data are expressed as mean±s.d. positive cells and are representative of triplicate experiments. *P<0.05.
